You are here

  • Home
  • Archive
  • Volume 1, Issue 3
  • NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

Article metrics

Article menu
Download PDFPDF
Clinical quality
NICE guidance for anti-tumour necrosis factor therapy in Crohn's disease: what does it mean for the inflammatory bowel disease community?

 

Online download statistics by month:

Online download statistics by month: August 2010 to March 2024

AbstractFullPdf
Aug 2010086
Sep 201001213
Oct 201001426
Nov 201001815
Dec 20100812
Jan 2011031
Feb 201101415
Mar 201101313
Apr 20110010
May 2011022
Jun 2011021
Jul 2011031
Aug 2011011
Sep 2011001
Oct 2011022
Nov 2011024
Jan 2012034
Feb 2012011
Mar 2012061
Apr 2012010
May 2012012
Jun 2012001
Jul 2012001
Aug 2012013
Sep 2012041
Oct 20120106
Nov 2012070
Dec 2012041
Jan 2013021
Feb 2013011
Mar 2013033
Apr 2013020
May 2013030
Jun 2013020
Jul 2013101
Dec 2013210
Jan 2014001
Feb 2014002
Mar 2014110
Apr 2014320
Jun 2014010
Jul 2014110
Aug 2014100
Sep 2014101
Nov 2014201
Jan 2015200
Feb 2015010
Mar 2015101
Apr 2015001
May 2015030
Jun 2015001
Jul 2015001
Sep 2015001
Nov 2015100
Dec 2015100
Jan 2016111
Mar 2016101
Apr 2016100
May 2016152
Jun 2016101
Oct 2016030
Nov 2016010
Dec 2016020
Jan 2017020
Mar 2017010
Apr 2017060
Aug 2017001
Oct 2017001
Dec 2017011
Feb 2018021
Mar 2018010
Apr 2018011
May 2018032
Jul 2018010
May 2019010
Jun 2019011
Jul 2019010
Aug 2019011
Oct 2019011
Nov 2019022
Dec 2019011
Feb 2020021
Mar 2020022
Jun 2020010
Jul 2020011
Dec 2020020
Jan 2021010
Feb 2021010
Aug 2021010
Dec 2021011
Jan 2022011
Apr 2022010
May 2022020
Oct 2022001
Nov 2022010
Feb 2023020
Aug 2023021
Nov 2023011
Dec 2023021
Feb 2024011
Mar 2024081
Total22234190